Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Macrophages help activate hair follicle stem cells, affecting hair growth and skin repair.

Foxi3 expression in developing teeth and hair is controlled by the ectodysplasin pathway.

Heparan sulfate is important for hair growth, preventing new hair formation in mature skin, and controlling oil gland development.

PI3K/Akt pathway is crucial for hair growth and regeneration.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Macrophages help maintain mammary stem cells and tissue balance through specific signaling pathways.

Liposomal carriers can improve tissue regeneration by stabilizing and retaining growth factors.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Metal organic frameworks-based scaffolds show promise for tissue repair due to their unique properties.

PRP therapy helps heal pediatric surgical wounds faster and with fewer scars but needs more research for safety and cost.

Vitamin D is crucial for skin health and managing skin diseases.

Adipose tissue changes in obesity can trigger stress in fat cells.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Infectious cerebral vasculitis can be a severe complication of meningoencephalitis, regardless of the pathogen.

Understanding embryologic layers improves skin disorder diagnosis and supports developing targeted therapies.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Physical activity, height, and smoking affect prostate cancer risk.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.